Search

Alzheimer's disease

Lilly’s drug, donanemab is an intravenous antibody designed to remove deposits of a protein called beta amyloid from the brains of Alzheimer’s patients.

Lilly Alzheimer drug faces more delays as FDA plans hearing

Eli Lilly’s Alzheimer’s disease drug donanemab faces further delays in gaining approval, with US regulators planning to hold a hearing of external advisers to explore how safe the therapy is and how w...

Latest T-bills Treasury Bills Results & Interest News Latest SSB Singapore Savings Bonds News Latest COE Certificate of Entitlement News

Latest Johor-Singapore SEZ News Latest BTO Build To Order & Sales of Balance News Latest STI Straits Times Index News Latest SGX Dividends, Share Price News Latest Bonds Market News Latest Singapore Stocks To Buy News Latest Singapore Economy News

View More